Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 67296-2315

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 67296-2315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ipra-alb 30 Ct Brick Carton (Rpsc0200 Rdp Ipra Alb 30 Ct Brick Carton Pdf Proof)

Ipra-alb 30 Ct Brick Carton (Rpsc0200   Rdp Ipra Alb 30 Ct Brick Carton   Pdf Proof)
Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, 0.5 mg / 3 mg per 3 mL, by Redpharm Drug. The label indicates a prescription-only solution for oral inhalation, supplied in 30 sterile unit-dose vials (each 3 mL). The label includes dosage and ingredient information and a barcode.*
FDA Label Image

60 Ct Brick Carton (Rpsc0201 60 Ct Brick Carton)

60 Ct Brick Carton (Rpsc0201 60 Ct Brick Carton)
Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, 0.5 mg/3 mg per 3 mL. The label indicates the product is for oral inhalation only and is provided in 60 sterile unit-dose vials (2 pouches of 30 vials each). The labeler is Redpharm Drug with NDC 67296-2315. The design features a blue and purple color scheme with dosage and usage details prominently displayed.*
FDA Label Image

Ipra-alb 30 Ct Cards Carton (Rpsc0265 Rdp Ipra Alb 30 Ct Cards Carton Pdf Proof New)

Ipra-alb 30 Ct Cards Carton (Rpsc0265   Rdp Ipra Alb 30 Ct Cards Carton   Pdf Proof New)
Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg / 3 mg per 3 mL. The label shows it is a respiratory inhalation solution, prescription only. The product is supplied in 30 sterile unit-dose vials of 3 mL each, labeled with NDC 76204-600-05. The labeler is Ritedose Pharmaceuticals, with instructions for oral inhalation only and includes barcodes and batch codes.*
FDA Label Image

Rdp Ipra-alb 60 Ct Cards Carton (Rpsc0266 Rdp Ipra Alb 60 Ct Cards Carton Pdf Proof New)

Rdp Ipra-alb 60 Ct Cards Carton (Rpsc0266   Rdp Ipra Alb 60 Ct Cards Carton   Pdf Proof New)
Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg / 3 mg per 3 mL by Redpharm Drug, NDC 76204-600-12. The label shows it is Rx only and contains 60 x 3 mL sterile unit-dose vials (12 pouches of 5 vials each). The design includes a blue and purple color scheme with directions for oral inhalation use and storage instructions.*
FDA Label Image

Rdp Ipra-alb 30 Ct Singles Carton (Rpsc0301 Rdp Ipra Alb 30 Ct Singles Carton With New Design Pdf Proof)

Rdp Ipra-alb 30 Ct Singles Carton (Rpsc0301   Rdp Ipra Alb 30 Ct Singles Carton With New Design   Pdf Proof)
Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution 0.5 mg / 3 mg per 3 mL, a respiratory inhalation solution. The label indicates the product is for oral inhalation only, with NDC 76204-600-01. The label includes dosage and usage information and has branding for Ritedose Pharmaceuticals.*
FDA Label Image

Chemical Structure (Ipratropium 01)

Chemical Structure (Ipratropium 01)
Chemical structure of Ipratropium Bromide and Albuterol Sulfate, illustrating the molecular arrangement of these active ingredients found in the respiratory inhalation solution by Redpharm Drug.*
FDA Label Image

Chemical Structure (Ipratropium 02)

Chemical Structure (Ipratropium 02)
Chemical structure of Ipratropium Bromide, showing the molecular arrangement with a bromide ion and hydrated water molecule indicated to the side, consistent with the active ingredient in Ipratropium Bromide and Albuterol Sulfate inhalation solution.*
FDA Label Image

Figure (Ipratropium 03)

Figure (Ipratropium 03)
A line graph depicting lung function in liters over time (hours after dosing) comparing Albuterol, Ipratropium, and a combination of Ipratropium Bromide and Albuterol Sulfate. The x-axis shows time in hours from 0 to 8, and the y-axis shows volume in liters, ranging from -0.05 to 0.35.*
FDA Label Image

Figure 1 (Ipratropium 04)

Figure 1 (Ipratropium 04)
Illustration showing a hand holding a solution vial tilted to pour liquid into the chamber of a respiratory inhalation device. The image demonstrates how to load the solution into the inhaler mechanism for administration.*
FDA Label Image

Figure 2 (Ipratropium 05)

Figure 2 (Ipratropium 05)
An instructional diagram showing the assembly or use of an inhalation device with a nozzle and mouthpiece components. A hand is holding part of the device, and the alignment of parts is indicated for respiratory solution administration.*
FDA Label Image

Figures 3 And 4 (Ipratropium 06)

Figures 3 And 4 (Ipratropium 06)
Instructional diagram showing two figures demonstrating how to use a respiratory inhalation device with a solution. Figure 3 depicts a person inhaling the medication directly through a mouthpiece. Figure 4 shows a person using a spacer or holding chamber attached to the inhaler for inhalation.*
FDA Label Image

Rdp Logo (Ipratropium 07)

Rdp Logo (Ipratropium 07)
The packaging label for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE inhalation solution by Redpharm Drug is shown. The label features the brand name Ritedose Pharmaceuticals and includes space for dosage information and directions. The product is a respiratory inhalation solution, with specified strengths on the label. The packaging is primarily white with blue and orange text accents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.